jcp Videos

Videos

Strategies the Health Care Industry Can Implement to Improve Black Women’s Participation in Clinical Trials

12/28/2023

Featuring Kianta Key

Kianta Key, Group Senior Vice President for GCI Health, explained the different influences and societal factors for why Black women are underrepresented in clinical trials and how the health care industry can create changes to diversify...

Kianta Key, Group Senior Vice...

12/28/2023

Journal of Clinical Pathways

Videos

Increasing Biomarker Testing Rates for Patients With NSCLC

12/07/2023

Featuring David Waterhouse, MD, MPH

Featuring David Waterhouse, MD, MPH ...

David Waterhouse, MD, MPH, talks about OHC’s quality improvement project that increased biomarker testing rates for patients with metastatic NSCLC, and shared how the program can be scaled to other practices and other cancers.

David Waterhouse, MD, MPH, talks...

12/07/2023

Journal of Clinical Pathways

Videos

Players and Disruptors in Health Care Industry Consolidation

12/05/2023

Featuring Ronald Barkley, MS, JD

Featuring Ronald Barkley, MS, JD ...

Ronald Barkley, MS, JD, Cancer Center Business Development Group, provides an overview of the current consolidation of the health care industry and the major players and disruptors leading this transformation.

Ronald Barkley, MS, JD, Cancer...

12/05/2023

Cancer Care Business Exchange

Todd Schonherz, American Oncology Network

Videos

Healthcare Industry Consolidation And What This Means For Community Oncology Practices

11/21/2023

Featuring Todd Schonherz

Todd Schonherz, CEO of American Oncology Network, details his session on the impact that industry consolidation has had on community oncology practices at CPC+CBEx 2023.

Todd Schonherz, CEO of American...

11/21/2023

Journal of Clinical Pathways

PATHWAY DISRUPTORS

TOPAZ-1 Study Explores Potential Prognostic Factors of Overall Survival for Patients With Advanced Biliary Tract Cancer

11/17/2023

Featuring Aiwu Ruth He, MD, PhD

Featuring Aiwu Ruth He, MD, PhD ...

Aiwu Ruth He, MD, PhD, summarizes the phase 3 TOPAZ-1 study and discusses treatment approaches for patients with biliary tract cancer.

Aiwu Ruth He, MD, PhD,...

11/17/2023

Journal of Clinical Pathways

Nicolas Ferreyros, Community Oncology Alliance.

Videos

Updates from Washington Impacting Community Oncology Practices

11/15/2023

Featuring Nicolas Ferreyros

In this interview, Nicolas Ferreyros, managing director, Community Oncology Alliance, summarizes some of the latest developments from Washington that are impacting cancer care and providers in community oncology.

In this interview, Nicolas...

11/15/2023

Cancer Care Business Exchange

Lindsay Kehoe, Clinical Trial Transformation Initiative.

Videos

Clinical Trials in the Community Setting Re-Envisioned

11/15/2023

Featuring Lindsay Kehoe

Lindsay Kehoe, MS, CGC, from Duke University/Clinical Trial Transformation Initiative, details her session on clinical trials in the community setting at the 2023 CPC & CBEx conference.

Lindsay Kehoe, MS, CGC, from...

11/15/2023

Journal of Clinical Pathways

Ruben A. Mesa, MD, FACP, Atrium Health Wake Forest Baptist Comprehensive Cancer Center

Videos

Novel Advances in the Treatment of Patients With Myelofibrosis

11/07/2023

Featuring Ruben A. Mesa, MD, FACP

Featuring Ruben A. Mesa, MD, FACP ...

At the 2023 Lymphoma, Leukemia & Myeloma Congress in New York, Ruben A. Mesa, MD, FACP, discusses the latest updates in myelofibrosis treatment.

At the 2023 Lymphoma, Leukemia &...

11/07/2023

Lymphoma, Leukemia & Myeloma Network

Videos

What the Growth of Medicare Advantage Means for Value-Based Care in Community Oncology

11/06/2023

Featuring David Eagleton

David Eagleton, Oncology Care Partners, shares his thoughts on the growth of Medicare Advantage and its impact on community oncology practices in providing value-based care.

David Eagleton, Oncology Care...

11/06/2023

Journal of Clinical Pathways

Videos

How Technologies and New Models Are Changing Clinical Research

11/02/2023

Featuring Sibel Blau, MD

Sibel Blau, MD, provides insights into the current state of clinical research in the oncology community and how technologies and new models are impacting this area.

Sibel Blau, MD, provides...

11/02/2023

Journal of Clinical Pathways

Current Issue

June 2024

Volume 10

Issue 3

Current Issue

Issue Archive

Special Reports

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Winston Wong, PharmD

Gordon Kuntz

Robin T Zon, MD, FACP, FASCO

2021 Care Pathways Working Group

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

$Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma$

Special Report

Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma

01/14/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Videos

Current Issue

Special Reports

Subscribe

Specialties

Events

Year Round Education

HMP Global Products